American multinational corporation Johnson & Johnson (J&J) has announced that its lead vaccine candidate pr...
Pfizer Inc. and BioNTech SE have announced an agreement with the Ministry of Health, Labour and Welfare (MHLW) in Japan ...
The two leading vaccine candidates CanSinoBIO of China and AZD1222 of UK have proven the safety and efficacy a...
The next critical phase for Australia's University of Queensland’s COVID-19 vaccine is underway – with the r...
CanSino Biologics Inc., an innovative biopharmaceutical company dedicated to vaccine R&D and commercialization, has ...
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has announced that its subsidiary Shanghai Fosun Pharmaceutical Industri...
Sanofi Pasteur, the vaccines global business unit of Sanofi, and Translate Bio, a clinical-stage messenger RNA (mRNA) th...
The Osaka-based Japanese biotech AnGes Inc. expects its potential COVID-19 vaccine to be ready as early as the first hal...
The Phase I/II clinical trials of the world's first inactivated COVID-19 vaccine, developed by Wuhan Institute of Biolog...
South Korea based Genexine has announced that it is the first domestic pharmaceutical company to have been approved for ...
Ten COVID-19 vaccine candidates are currently in clinical trials (as of 4 June). These are listed in the below, in appro...
Clover Biopharmaceuticals, headquartered in China, has announced that the first participants have been dosed in the Phas...
Daiichi Sankyo Company, Limited has announced its decision to develop a genetic (mRNA) vaccine for the novel corona viru...
Serum Institute of India (SII) is the world’s largest vaccine producer in terms of volume. SII is currently workin...
In collaboration with the International Pharmaceutical Students’ Federation’s (IPSF) and the International F...
China-based Sinovac Biotech Ltd. inked a clinical development collaboration agreement with a Brazilian producer of immun...
Gernam firm BioNTech SE closed USD112.55 million debt financing agreement to support the development of the company&rsqu...
Moderna, Inc. announced on 11 June 2020 about progress on the late-stage development of mRNA-1273, the Company&rsqu...
